Rosette spectroscopic imaging for whole-brain metabolite mapping at 7T: acceleration potential and reproducibility
Abstract
Whole-brain proton magnetic resonance spectroscopic imaging (1H-MRSI) is a non-invasive technique for assessing neurochemical distribution in the brain, offering valuable insights into brain functions and neural diseases. It greatly benefits from the improved SNR at ultrahigh field strengths ($\geq$7T). However, 1H-MRSI still faces several challenges, such as long acquisition time and severe signal contaminations from water and lipids. In this study, 2D and 3D short TR/TE 1H-FID-MRSI sequences using rosette trajectories were developed with spatial resolutions of 4.48$\times$4.48 mm$^2$ and 4.48$\times$4.48$\times$4.50 mm$^3$, respectively. Water signals were suppressed using an optimized Five-variable-Angle-gaussian-pulses-with-ShorT-total-duration of 76 ms (FAST) water suppression scheme, and lipid signals were removed using the L2 regularization method. Metabolic maps of major 1H metabolites were obtained within 5:40 min with 16 averages and 1 average for the 2D and 3D acquisitions, respectively. Excellent inter-session reproducibility was shown, with the coefficients of variance (CV) being lower than 6% for N-Acetyle-L-aspartic acid (NAA), Glutamate (Glu), Choline Chloride and glycerophosphocholine (tCho), Creatine and Phosphocreatine (tCr), and Glycine and Myo-inositol (Gly+Ins). To explore the potential of further accelerating the acquisition, compressed sensing was applied retrospectively to the 3D datasets. The structural similarity index (SSIM) remained above 0.85…
Read the paper
Related studies
- Biportal endoscopic versus microscopic lumbar decompressive laminectomy in patients with spinal stenosis: A randomized controlled trial
- A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial
- Supplement-based nutritional strategies to tackle frailty: A multifactorial, double-blind, randomized placebo-controlled trial
- A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
- Creatine supplementation (3 g/day) and bone health in older women: a 2-year, randomized, placebo-controlled trial
- A Multi-Ingredient Nutritional Supplement in Combination With Resistance Exercise and High-Intensity Interval Training Improves Cognitive Function and Increases N-3 Index in Healthy Older Men: A Randomized Controlled Trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.